Amalgamated Bank Amphastar Pharmaceuticals, Inc. Transaction History
Amalgamated Bank
- $13.6 Billion
- Q3 2025
A detailed history of Amalgamated Bank transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 10,494 shares of AMPH stock, worth $265,078. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,494
Previous 10,549
0.52%
Holding current value
$265,078
Previous $242,000
15.29%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding AMPH
# of Institutions
263Shares Held
33MCall Options Held
18.3KPut Options Held
13K-
Black Rock Inc. New York, NY5.94MShares$150 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.69MShares$67.9 Million0.0% of portfolio
-
Td Asset Management Inc2.03MShares$51.4 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.63MShares$41.1 Million0.01% of portfolio
-
State Street Corp Boston, MA1.58MShares$39.8 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.24B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...